News

The FDA has proposed regulating the cosmetic industry, says Dr. Zoe Diana Draelos in her monthly Dermatology Times column, "Cosmetic Conundrums." This month Dr. Draelos examines three key questions about cosmetic safety.

Soap has probably done more to improve world health than any prescription medication, says Dr. Zoe Diana Draelos in her monthly Dermatology Times column, "Cosmetic Conundrums."

In 2018 at just five days into the New Year, a search of PubMed revealed 86 new psoriasis studies. So, who is leading the pack?

Study shows no significant difference in herpes zoster risk between psoriasis patients receiving systemic therapy and those not receiving systemic therapy.

Dr. Derm logged into his office computer system, only to find a ransom note from a hacker, asking for money in exchange for the safe return of his patients’ records. Who are these hackers? How do they gain access? What should Dr. Derm do?

Although most malpractice cases against dermatologists are abandoned, withdrawn or dismissed, communication with patients may minimize liability.

Neural networks do pattern recognition just as a dermatologist would learn patterns and visual data. Computer accuracy rivals that of humans for classifying skin cancer. Deep neural networks and artificial intelligence may have a growing role in practice.

The cost of doxycycline hyclate prescriptions increased 1,854% between 2011 and 2013 in a retrospective analysis of commercial claims data, and there was no association between market concentration and price of the oral antibiotic. Clinician or pharmacy level interventions to choose less costly oral tetracycline-class antibiotics could result in substantial cost savings.

Dermatologists need to be aware of margin of error and related issues that can affect the results of biosimilar clinical trials, a study shows.

What exciting new devices, drugs and treatments will the New Year bring dermatologists and their patients? Physicians in the specialty and others share what they most anticipate in the coming year.

The dermatology community experienced big strides in medical and cosmetic dermatology in 2017. Dermatologists share what they think were major breakthroughs throughout the year.

In this installment of our melanoma case studies series, we focus on common cancers in unusual locations versus uncommon cancers in classic locations.

The holidays can be stressful, but rest assured, you can get through them with peace and joy instead of tension and oy vey. It just takes some mindfulness.

Weren’t we all preparing for the holidays in 2016 about a week ago? Time flies when you’re helping patients. To that end, we asked dermatologists to reflect on 2017, and summarize it using just one word (or two) with a brief explanation.

With the internet being available at everyone's fingertips and seemingly endless advertising for a variety of skincare and cosmetic products, the average patient may come to an appointment with misinformation and questions.

Thinking of psoriasis and atopic dermatitis as a spectrum, rather than separate diseases might lead to better understanding, and potentially better treatments.

A retrospective study shows that early propranolol-induced heart rate reductions fail to predict clinical response of infantile hemangiomas.

Ocular comorbidity risk is already high in patients with atopic dermatitis and may increase even further as biologic agents are introduced, a study shows.

ISSVA clinical classifications aren't enough to accurately identify vascular malformation subtypes, according to a recent review.

Adult AD may be influenced by childhood eczema, though most adults have no memory of childhood eczema.

A retrospective review of pediatric patients treated for psoriasis with systemic agents provides much needed insight about the safety and tolerability of these medications.

Survey highlights the challenges of controlling psoriasis flares.

Environmental and lifestyle factors, such as certain foods and infections, may trigger onset of psoriasis and account for approximately 30% of the risk of the condition in people with a genetic preposition, research presented in London shows.

Psoriasis has long been linked with poor nutrition, high body mass index and metabolic disorders. New research suggests a reduced sense of taste and smell, caused by inflammation, may explain why.

Psoriasis patients carrying a specific gene experience a significantly better early response to ustekinumab, but are less likely to achieve high rates of response to anti-TNFs.

The spleen may have a role in driving the higher rate of cardiovascular disease seen in psoriasis patients through a spleen–atherosclerotic axis, suggests research presented at a meeting in London.

Pooled meta-analysis does not support association between isotretinoin treatment for acne and worsening of depression.

A lower level concentration of ingenol mebutate gel for the chest significantly reduces actinic keratosis lesion counts without severe side effects, a study shows.

The lack of serious laboratory abnormalities in patients on isotretinoin suggests that reduced monitoring may suffice.